Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
The New England journal of medicine 2008-03-27
Hydroxyurea for the treatment of sickle cell anemia.
Related Questions
What is your strategy for optimizing hydroxyurea dosage in patients with symptomatic sickle cell disease, particularly for genotypes HbSS and HbS/Beta thal?
New answer
by at FibroFighters Foundation (April 28, 2024)
I am far, far more worried about underdosing than overdosing. Although HgF is the traditional lab parameter, it may not go up in all patients. I also look for a decrease in re...
Read more (1 Answer available)
19642
×
To continue please login or register
Register
or
Sign in